diltiazem has been researched along with No-Reflow Phenomenon in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bing, R; Lowe, HC | 1 |
| Fu, X; Geng, W; Li, W; Peng, Y; Ru, L; Sun, J; Xing, K; Zhao, Y | 1 |
| Cheng, Z; Gu, Y; Peng, D; Wang, L | 1 |
| Bernal, JM; Cubeddu, RJ; Don, CW; Kiernan, GD; Kiernan, TJ; Ruggiero, NJ; Witzke, C; Yan, BP | 1 |
| Bai, Y; Cheng, Z; Gao, B; Gu, Y; Hou, L; Hu, L; Li, L; Liu, T | 1 |
| Celik, A; Dogan, A; Elbasan, Z; Gur, M; Inanc, MT; Kalay, N; Oguzhan, A; Orscelik, O; Ozdogru, I; Zencir, C | 1 |
| Chen, XB; Li, CC; Mo, L; Peng, DD; Pu, XQ; Yang, TL; Yu, ZX; Zheng, ZF | 1 |
2 review(s) available for diltiazem and No-Reflow Phenomenon
| Article | Year |
|---|---|
Short-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled Trials.
Topics: Calcium Channel Blockers; Cardiovascular Agents; Diltiazem; Humans; No-Reflow Phenomenon; Randomized Controlled Trials as Topic; Verapamil | 2015 |
The no-reflow phenomenon in the coronary circulation.
Topics: Adenosine; Animals; Coronary Circulation; Diltiazem; Humans; Nicardipine; Nicorandil; Nitroprusside; No-Reflow Phenomenon; Prostheses and Implants; Vasodilator Agents; Verapamil | 2009 |
3 trial(s) available for diltiazem and No-Reflow Phenomenon
| Article | Year |
|---|---|
Effect of intracoronary anisodamine and diltiazem administration during primary percutaneous coronary intervention in acute myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Arrhythmias, Cardiac; China; Coronary Angiography; Diltiazem; Drug Therapy, Combination; Female; Humans; Injections, Intra-Arterial; Male; Middle Aged; Myocardial Infarction; No-Reflow Phenomenon; Prospective Studies; Solanaceous Alkaloids; Stents; Time Factors; Treatment Outcome; Vasodilator Agents | 2014 |
A randomized, single-center double-blinded trial on the effects of diltiazem sustained-release capsules in patients with coronary slow flow phenomenon at 6-month follow-up.
Topics: Administration, Oral; Arrhythmias, Cardiac; Blood Flow Velocity; Capsules; Coronary Angiography; Coronary Disease; Death; Diltiazem; Double-Blind Method; Exercise Test; Female; Follow-Up Studies; Heart Rate; Hospitalization; Humans; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; No-Reflow Phenomenon; Prognosis; Ventricular Function, Left | 2012 |
Acute effects of intracoronary nitroglycerin and diltiazem in coronary slow flow phenomenon.
Topics: Adult; Aged; Coronary Vessels; Diltiazem; Female; Humans; Injections, Intra-Arterial; Male; Middle Aged; Nitroglycerin; No-Reflow Phenomenon; Prospective Studies | 2013 |
2 other study(ies) available for diltiazem and No-Reflow Phenomenon
| Article | Year |
|---|---|
No reflow in ST elevation myocardial infarction: a new way forward?
Topics: Angioplasty, Balloon, Coronary; Arrhythmias, Cardiac; Diltiazem; Female; Humans; Male; Myocardial Infarction; No-Reflow Phenomenon; Solanaceous Alkaloids; Vasodilator Agents | 2014 |
[Effects of intracoronary diltiazem on no-reflow phenomenon after emergent percutaneous coronary intervention in patients with acute myocardial infarction].
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Diltiazem; Female; Humans; Male; Middle Aged; Myocardial Infarction; No-Reflow Phenomenon; Stents; Treatment Outcome | 2006 |